Commentary—Goodbye M(C)ID! Hello MID, Where Do You Come From?
Holger J. Schünemann
Address correspondence to Holger J. Schünemann, M.D., Ph.D, M.Sc., CLARITY GROUP, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Dr. Schünemann and Gordon H. Guyatt M.D., MSc. are with the CLARITY Group, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Dr. Schünemann is also with the Department of Medicine, University of Buffalo, New York, USA and INFORMA, National Cancer Institute, Rome, Italy. Dr. Guyatt is also with the Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Search for more papers by this authorGordon H. Guyatt
Search for more papers by this authorHolger J. Schünemann
Address correspondence to Holger J. Schünemann, M.D., Ph.D, M.Sc., CLARITY GROUP, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Dr. Schünemann and Gordon H. Guyatt M.D., MSc. are with the CLARITY Group, Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Dr. Schünemann is also with the Department of Medicine, University of Buffalo, New York, USA and INFORMA, National Cancer Institute, Rome, Italy. Dr. Guyatt is also with the Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Search for more papers by this authorGordon H. Guyatt
Search for more papers by this author
References
- Guyatt, G. H., D. Osoba, A. W. Wu, K. W. Wyrwich, G. R. Norman, and Clinical Significance Consensus Meeting. 2002. “Methods to Explain the Clinical Significance of Health Status Measures. Mayo Clinic Proceedings 77 (4): 371–83.
- Guyatt, G., V. Montori, P. J. Devereaux, H. Schünemann, and M. Bhandari. 2004. “Patients at the Centre: In Our Practice, and in Our Use of Language. ACP Journal Club 140: A-11.
- Jaeschke, R., J. Singer, and G. H. Guyatt. 1989. “Measurement of Health Status. Ascertaining the Minimal Clinically Important Difference. Controlled Clinical Trials 10 (4): 407–15.DOI: 10.1016/0197-2456(89)90005-6
- Juniper, E. F., G. H. Guyatt, A. Willan, and L. E. Griffith. 1994. “Determining a Minimal Important Change in a Disease-Specific Quality of Life Questionnaire. Journal of Clinical Epidemiology 47 (1): 81–7.DOI: 10.1016/0895-4356(94)90036-1
- Lassere, M. N., D. Van Der Heijde, and K. R. Johnson. 2001. “Foundations of the Minimal Clinically Important Difference for Imaging. Journal of Rheumatology 28: 890–1.
- Puhan, M. A., M. Behnke, P. J. Devereaux, V. M. Montori, O. Braendli, M. Frey, and H. J. Schünemann. 2004. “Measurement of Agreement on Health-Related Quality of Life Changes in Response to Respiratory Rehabilitation by Patients and Physicians—A Prospective Study. Respiratory Medicine 98 (12): 1195–202.DOI: 10.1016/j.rmed.2004.04.011
- Schünemann, H., M. Puhan, R. Goldstein, R. Jaeschke, and G. Guyatt. 2005. “Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). Journal of COPD (in press).
- Sneeuw, K. C. A., M. A. G. Sprangers, and N. K. Aaronson. 2002. “The Role of Health Care Providers and Significant Others in Evaluating the Quality of Life of Patients with Chronic Disease. Journal of Clinical Epidemiology 55 (11): 1130–43.DOI: 10.1016/S0895-4356(02)00479-1
- Ubel, P., G. Loewenstein, and C. Jepson. 2003. “Whose Quality of Life? A Commentary Exploring Discrepancies between Health State Evaluations of Patients and the General Public. Quality Life Research 12: 609–10.DOI: 10.1023/A:1025151424576
- Von Essen, L. 2004. “ Proxy Ratings of Patient Quality of Life–Factors Related to Patient-Proxy Agreement. Acta Oncology 43 (3): 229–34.DOI: 10.1080/02841860410029357
- Wyrwich, K. W., S. D. Fihn, W. M. Tierney, K. Kroenke, A. N. Babu, and F. D. Wolinsky. 2003. “Clinically Important Changes in Health-Related Quality of Life for Patients with Chronic Obstructive Pulmonary Disease. An Expert Consensus Panel Report. Journal of General Internal Medicine 18 (3): 196–202.DOI: 10.1046/j.1525-1497.2003.20203.x
- Wyrwich, K. W., W. M. Tierney, A. N. Babu, K. Kroenke, and F. D. Wolinsky. 2005. “A Comparison of Clinically Important Differences in Health-Related Quality of Life for Patients with Chronic Lung Disease, Asthma or Heart Disease. Health Services Research 40 (2): 577–92.
Citing Literature
